Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
The European Respiratory Journal|August 30, 2022
Nintedanib in children and adolescents with fibrosing interstitial lung diseasesRobin Deterding, Lisa R Young, Emily M DeBoer, et al.
The European Respiratory Journal|February 28, 2002
Clinical significance of histological classification of idiopathic interstitial pneumoniaK R Flaherty, G B Toews, W D Travis, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2022
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)Fernando J Martinez, Marlies S Wijsenbeek, Ganesh Raghu, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2016
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis OutcomesMargaret L Salisbury, David A Lynch, Edwin J R van Beek, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
Thorax|January 30, 2003
Radiological versus histological diagnosis in UIP and NSIP: survival implicationsK R Flaherty, E L Thwaite, E A Kazerooni, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
Annals of the American Thoracic Society|September 11, 2023
Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography PatternAndrea S Oh, David A Lynch, Jeffrey J Swigris, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosisCharlene D Fell, Fernando J Martinez, Lyrica X Liu, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
The European Respiratory Journal|August 30, 2022
Nintedanib in children and adolescents with fibrosing interstitial lung diseasesRobin Deterding, Lisa R Young, Emily M DeBoer, et al.
The European Respiratory Journal|February 28, 2002
Clinical significance of histological classification of idiopathic interstitial pneumoniaK R Flaherty, G B Toews, W D Travis, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2022
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)Fernando J Martinez, Marlies S Wijsenbeek, Ganesh Raghu, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2016
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis OutcomesMargaret L Salisbury, David A Lynch, Edwin J R van Beek, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
Thorax|January 30, 2003
Radiological versus histological diagnosis in UIP and NSIP: survival implicationsK R Flaherty, E L Thwaite, E A Kazerooni, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
Annals of the American Thoracic Society|September 11, 2023
Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography PatternAndrea S Oh, David A Lynch, Jeffrey J Swigris, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosisCharlene D Fell, Fernando J Martinez, Lyrica X Liu, et al.
Pageof 25